Mission BioCapital

Company

Investment-firm

Last deal

$11M

Amount

Venture - Series Unknown

Stage

19.05.2021

Date

1

all rounds

$11M

Total amount

Financing round

General

About Company
Mission BioCapital is a life science venture capital firm that invests in early-stage companies in the biotech sector.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

Number of employees

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Founded in 2009 and located in Cambridge, Massachusetts, with an additional office in San Francisco, California, Mission BioCapital's leadership team has a long history of investing in and launching dozens of early-stage life science companies. They are known for providing deep support and expertise to portfolio companies, and they offer lab space, capital, and strategic partnerships to support companies from ideation to exit.
Contacts
Similar Companies
999
Mission Bay Capital

Mission Bay Capital

Mission Bay Capital is a venture firm investing in bioscience startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

San Francisco, CA, USA

count Of Investments

24

count Of Exists

3
Columbus Venture Partners

Columbus Venture Partners

Columbus Venture Partners is a Madrid-based venture capital firm that invests in early-stage life science technology companies in Spain.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Biotechnology

count Of Investments

14

count Of Exists

2
Ysios Capital

Ysios Capital

Ysios Capital provides venture capital funding to Spanish life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Biotechnology

Location

Donostia-San Sebastian, Gipuzkoa, Spain

count Of Investments

63

count Of Exists

9
Bioqube Ventures

Bioqube Ventures

Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Life Science

Location

Hasselt, Belgium

count Of Investments

10

Financials

Funding Rounds
1
1

Number of Funding Rounds

$11M

Money Raised

Their latest funding was raised on 19.05.2021. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
19.05.2021
$11M
Investments
55
Date 
name 
Lead 
type 
Raised 
Vaxess Technologies

Vaxess Technologies

Vaxess Technologies develops biomedical innovations to improve access to vaccines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Biotechnology, Health Care, Venture Capital

Location

Cambridge, MA, USA

total rounds

21

total raised

$120.2M
Nocion Therapeutics

Nocion Therapeutics

Nocion Therapeutics develops pharmaceuticals to treat neurogenic inflammation conditions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

4

total raised

$111M
Mediar Therapeutics

Mediar Therapeutics

Mediar is a biotech company that develops therapeutics for the treatment of fibrosis.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

4

total raised

$116.76M
Co-Investors
Exits
11
Mitokinin

Mitokinin

Mitokinin is a healthcare company that focuses on biotechnology for treating Parkinson's disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

San Francisco, CA, USA

total rounds

2

total raised

$5M
Comet Therapeutics

Comet Therapeutics

Comet Therapeutics develops and commercializes treatments for metabolic, neurological, and immunological disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

1

total raised

$28.5M
Redwood Bioscience

Redwood Bioscience

Redwood Bioscience develops optimized and novel biotherapeutics using precision protein-chemical engineering.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology

Location

Emeryville, CA, USA

total rounds

7

total raised

$12.86M

People

Founders
2
Peter Parker
Peter Parker

Peter Parker

Peter joined Ampersand in 1988 and served as a General Partner for 18 years. Subsequently, he joined Cequent Pharmaceuticals, an Ampersand portfolio company, as CEO in 2006 before returning to Ampersand as a Senior Advisor in 2011. Peter currently serves on the boards of ATS Labs and Biomedical Structures. Prior to joining Ampersand, Peter spent 14 years at AMAX. He holds an M.S. in Chemical Engineering from Columbia.

current job

LabCentral
LabCentral

Peter Parker

Johannes Fruehauf
Johannes Fruehauf

Johannes Fruehauf

Johannes Fruehauf is the Founder & CEO LabCentral/Biolabs.He is responsible for all aspects of LabCentral’s operation. Johannes is a physician and successful biotech entrepreneur. Prior to LabCentral, he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Johannes earned his medical degree at the University of Frankfurt and his PhD at the University of Heidelberg (Germany).

current job

Arkuda Therapeutics
Arkuda Therapeutics

Johannes Fruehauf

Employee Profiles
5
Douglas Crawford

Douglas Crawford

Managing Partner

Eric W. Linsley

Eric W. Linsley

Managing General Partner

Johannes Fruehauf

Johannes Fruehauf

General Partner, Co-Founder

Peter Parker

Peter Parker

Managing General Partner

Activity

Recent News
4
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month